Asserter profile

REGENERON PHARMACEUTICALS, INC.

operating company3 patents now3 ever5 cases filed during tenure3 connections

PTAB exposure

3of this entity’s patents have been challenged at PTAB (4 total proceedings). 1 currently have active proceedings.

Two-hop network

Edges marked ⚖️ overlap with at least one infringement suit filed during the receiving entity’s tenure with the patent. Bold-bordered = this entity. Red = NPE; orange = shell LLC; green = defensive aggregator; blue = operating company.

flowchart LR
    Nregeneron_pharmaceuticals["REGENERON PHARMACEUTICALS, INC."]
    Ndix_daniel_graham_kenneth_s_furfine_eric_frye_kelly["DIX, DANIEL; GRAHAM, KENNETH S.; FURFIN…"]
    Nyancopoulos_george_d["YANCOPOULOS, GEORGE D."]
    Nwadhwa_saurabh_graham_kenneth_s["WADHWA, SAURABH; GRAHAM, KENNETH S."]
    Ndix_daniel_graham_kenneth_s_furfine_eric_frye_kelly ==>|"⚖️ 2020 · Assignment · 11084865"| Nregeneron_pharmaceuticals
    Nyancopoulos_george_d -->|"2018 · ASSIGNMENT OF ASSIGNORS INTEREST · 10828345"| Nregeneron_pharmaceuticals
    Nwadhwa_saurabh_graham_kenneth_s -->|"2021 · ASSIGNMENT OF ASSIGNORS INTEREST · 12168036"| Nregeneron_pharmaceuticals
    classDef focal fill:#fef3c7,stroke:#92400e,stroke-width:3px,color:#1c1917
    classDef npe fill:#fee2e2,stroke:#be123c,stroke-width:2px,color:#1c1917
    classDef shell fill:#fed7aa,stroke:#9a3412,stroke-width:2px,color:#1c1917
    classDef defensive fill:#dcfce7,stroke:#15803d,stroke-width:2px,color:#1c1917
    classDef operating fill:#e0f2fe,stroke:#075985,stroke-width:1px,color:#1c1917
    class Nregeneron_pharmaceuticals focal

Patents currently held (3)

Connected entities (3)

Correspondent attorneys (2)

Attorneys / firms recorded with USPTO when this entity received a patent. Recurrence is the signal — many firms do both NPE and operating-company patent work, so a single appearance doesn’t mean much.